We serve Chemical Name:1-(3-methylphenyl)pyrrole-2,5-dione CAS:20299-79-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(3-methylphenyl)pyrrole-2,5-dione
CAS.NO:20299-79-0
Synonyms:N-m-tolyl-maleimide;N-m-Tolyl-maleinimid
Molecular Formula:C11H9NO2
Molecular Weight:187.19500
HS Code:2925190090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:333.5ºC at 760mmHg
Density:1.277g/cm3
Index of Refraction:1.615
PSA:37.38000
Exact Mass:187.06300
LogP:1.48940
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like N-m-tolyl-maleimide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-m-Tolyl-maleinimid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-m-Tolyl-maleinimid Use and application,N-m-Tolyl-maleinimid technical grade,usp/ep/jp grade.
Related News: Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California. 1-(3-methylphenyl)pyrrole-2,5-dione manufacturer Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California. 1-(3-methylphenyl)pyrrole-2,5-dione supplier Government officials say that the number of visitors from the mainland and other countries has decreased significantly after they closed several border points and rail stations and cut flight arrivals by half. 1-(3-methylphenyl)pyrrole-2,5-dione vendor Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California. 1-(3-methylphenyl)pyrrole-2,5-dione factory The government is leveraging its large patient population to push non-domestic drugs companies to cut prices to their lowest level globally.